Pharmaceutical-Tech portal endeavors to provide crucial and encapsulated information in various formats. Through the following interviews, our visitors can use the experience and opinions of key decision-makers as well as industry leaders by implementing it in their individual ventures.

Catherine Sabatos-Peyton

Catherine Sabatos-Peyton, Senior Investigator II, Immuno-oncology, Novartis Institutes for BioMedical Research: After graduating from Fordham University with a B.S. in Biology, Catherine spent a year at the University of Oxford on a Fulbright Fellowship, studying the role of the immune system in autoimmune diseases. During her Ph.D. in Immunology at…

Radboud University Medical Center

Dr. Verdurmen has done his his PhD on the cellular delivery of biomacromolecules at the Radboud University in Nijmegen, focusing on the use of cell-penetrating peptides. After finishing his PhD cum laude, he received a postdoctoral fellowship that he used to join the laboratory of Andreas Plückthun in order to…

Dr Abhinav Shukla
KBI Biopharma

Abhinav has over 15 years of experience in process development in biopharmaceuticals covering early development through commercial launch. He has led process development activities at both small biopharmaceutical and large pharmaceutical organizations and was most recently the Director, Manufacturing Sciences and Technology at Bristol-Myers Squibb. At BMS, Abhinav led an…

Dr. Christian Korz
Roche Diagnostics

Dr. Christian Korz joined the Roche Life Science Alliances team in July 2014. He is associated with the Swiss country organization working as a Pharma Alliance Manager with Novartis and managing the relationship with the Roche Pharma Division for the EMEA LATAM region. He supports the strategic needs of his…

Beat Rupp
Hapa AG

Hapa Services generates over 50% of turnover. The department features a regional setup, with close ties to regional partners and customers and a focus on product updates and promotions.

Dr. Jef Verplaetse
Laboratoria Smeets N.V

Counterfeit drugs should be mainly made impossible by a well functioning national health care system, whereby multiple step controls are making life for counterfeit drug producers more difficult.

Dr. Andrew Marr
Marr Consultancy Ltd

ISO IDMP is the next wave in the pharmacovigilance legislation after xEVMPD. But with a global scope and requiring data integration from the entire company it is a much bigger wave. In 2012, the five ISO standards referred to as “ISO IDMP” were approved. Their purpose is to standardise the…

Mr. Jagdish Saxena
Elder Pharma

If there’s one trait that embodies Jagdish Saxena, it’s perhaps the man’s mettle. The first public hint of that came in 1987 when Saxena was at the top of his career. In 27 years he had gone from a commissioned officer in the Indian Air Force to managing director of…